Clinical trial · Interventional
A Comparative Usability Study of Two Total Body Skin Imaging Systems
A Comparative Usability Study of Two Total Body Skin Imaging Systems: Vectra (3D Total Body Photography With Manual Dermoscopy) Versus Deviskan (Total Body Photography With Automated Non-Contact Dermoscopy)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma (Skin Cancer) | Melanoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Deviskan | Device | — | UNRESOLVED |
| Standard-of-care clinical examinations | Other | — | UNRESOLVED |
| Vectra WB360 | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Deviskan
- description
- Group Deviskan will be examined by Deviskan first followed by Vectra. Group Deviskan will receive questionnaire Version A, meaning questions referring to Deviskan are presented before those referring to Vectra.
- interventionNames
- Device: Deviskan
- Device: Vectra WB360
- Other: Standard-of-care clinical examinations
- type
- EXPERIMENTAL
- label
- Vectra
- description
- Group Vectra will be examined by Vectra first followed by Deviskan. Group Vectra will receive questionnaire Version B, meaning questions referring to Vectra are presented before those referring to Deviskan.
- interventionNames
- Device: Deviskan
- Device: Vectra WB360
- Other: Standard-of-care clinical examinations
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years * Signed informed consent by the participant * Sufficient proficiency in German * At least one of the following risk criteria for melanoma: * Previous melanoma (including in situ) * Suspected melanoma * ≥ 100 common naevi * ≥ 5 dysplastic naevi * dysplastic naevus syndrome * Known CDKN2A mutation * Strong family history for melanoma (≥ first- and/or second-degree relatives) Exclusion Criteria: * Lack of informed consent * Immobility. (Patients must be able to stand without support for 30 minutes.) * Inability to follow the procedures of the investigation, including inability to follow on-screen instructions or to read (e.g. due to visual impairment or cognitive impairment) * Vulnerable Subjects * Active skin conditions that may impact the performance of TBP systems or skin cancer screenings * Cardiac pacemaker * Pregnant women (self reported, no pregnancy test planned) * Height below 150 cm or above 195 cm * Severe Claustrophobia
References
Publications (0)
Data not yet available